LaPorte Ag Therapeutics' Grant

LaPorte Ag Therapeutics raised a round of funding on May 19, 2017. Investors include Colorado Office of Economic Development and International Trade.

LaPorte Ag Therapeutics is the developer of MucosImmune, a liquid, topically-administered immunotherapeutic designed to improve on first generation injectable immune therapeutics for cattle.…

Articles about LaPorte Ag Therapeutics' Grant: